Estrogen Processing and Breast Cancer Risk Explain why estrogen concentration alone poorly predicts breast cancer risk Describe estrogen metabolic pathway bias (2-OH, 4-OH, 16-OH) Recognize the role of detox capacity, inflammation, and insulin signaling Apply a systems framework for prevention and risk reduction Case-Based Reflections on Risk-Informed Breast Cancer Screening Describe how breast density and … Continued
Identify key goals of medications for opioid use disorder (MOUD) initiation in the hospital emergency department and outpatient setting Perform patient assessment and compare initiation protocols for MOUD Outline follow-up, monitoring and access barriers
Our CCO discussed the 42 CFR Part 2 changes and how they align with HIPPA. Discussed how this changes disclosure and documentation changes Improves compliance between medical entities and improves documentation
Gain understanding of risk adjustment methodology and its role in Value Based Care models. Review specific official ICD-10-CM coding guidelines and how they are applied to diagnosis coding and reporting. Identify elements of the medical record that help support the validation of reported conditions. Identify documentation deficiencies for specific conditions.
Define coronary artery disease and discuss appropriate use of CAC, CTA, FFR and Plaque analysis.
Review the epidemiology, pathophysiology, and clinical presentation of atrial fibrillation. Discuss current diagnostic strategies and risk stratification tools, including CHA₂DS₂-VASc and bleeding risk assessment. Evaluate contemporary management approaches, including rate control, rhythm control, anticoagulation, and catheter ablation. Interpret recent guideline updates and clinical trials that influence the treatment of atrial fibrillation. Introduce findings from the … Continued
Unavailable
Gain understanding of risk adjustment methodology and its role in Value Based Care models. Review specific official ICD-10-CM coding guidelines and how they are applied to diagnosis coding and reporting. Identify elements of the medical record that help support the validation of reported conditions. Identify documentation deficiencies for specific conditions.
Unavailable
TBA
Define and discuss co-occurring disorders Identify needs and levels of care for those with co-occurring disorders
Understanding Peptide Therapies: Participants will learn about various peptides and their mechanisms of action. Clinical Applications: Attendees will explore how to apply peptide therapies in clinical settings, including potential benefits and risks. Patient Education: Participants will be equipped to effectively educate patients about these peptides, including their FDA status and informed consent requirements. Safety and … Continued
Unavailable
Unavailable
More than 100 million people in the U.S. experience various types of allergies each year, but many individuals go undiagnosed due to the complexity of allergy symptoms and the lack of formal diagnosis. According to a recent survey, 65% of individuals with unexplained symptoms discovered hidden allergens as the root cause of their ailments. This … Continued
Importance of clinical validation, documentation requirements for diagnoses to meet payor’s guidelines, a review of most common queries from the CDI specialist, and most frequent discussions CDI has with payors.
Unavailable
Describe common life outcomes and challenges experienced by autistic adults. Analyze barriers autistic adults may face in accessing employment, housing, and mental health services. Explain key considerations for caregivers and physicians when supporting autistic adolescents transitioning into young adulthood. Identify appropriate approaches for discussing sensitive issues such as sexuality with autistic young adults.
Recognize the landscape of modern oncology therapies relevant to internal medicine physicians. Explain the mechanisms of action and toxicity profiles of key drug classes (BiTEs, checkpoint inhibitors, CAR-T, antibody-drug conjugates and TKIs). Identify the clinical features and grading criteria for CRS and ICANS. Apply evidence-based monitoring and management strategies for oncology-related toxicities.TBA
Unavailable
Unavailable
Unavailable
Describe buprenorphine and outline how it fits into the framework of medication-assisted treatment (MAT)Recognize how buprenorphine works as a partial opioid agonist and its effects on the brain’s opioid receptors, including protocols for starting, adjusting, and maintaining therapy Discuss policies and regulations surrounding buprenorphine prescribing, including the role of waivered providers
© MeCop 2025. All rights reserved